Plenary Speaker
Carl Dieffenbach Ph.D
Director, DAIDS, NIAID
National Institutes of Health, Bethesda, MD
Title: Drug Development for HIV: We have come so far, and we are not yet done
Carl W. Dieffenbach, Ph.D., serves as Director of the Division of AIDS (DAIDS). Dr. Dieffenbach oversees a global HIV/AIDS research portfolio of more than $1 billion and a staff of more than 150 federal employees. He played a key role in restructuring the DAIDS-supported clinical trials research networks and has actively fostered collaboration and partnerships with other federal agencies, international research organizations, foundations, and industry. In 1992, he joined DAIDS as the chief of the preclinical therapeutics group. Upon his appointment, Dr. Dieffenbach spearheaded important research initiatives that accelerated the progress of basic research on HIV pathogenesis and directly resulted in new clinical studies of novel AIDS therapies. In 1996, he was promoted to Director of the DAIDS Basic Sciences Program, where he remained until being selected as the division director in 2008. In 2011, Dr. Dieffenbach received the Distinguished Alumnus Award of the Department of Chemistry and Biochemistry, University of Maryland.
Keynote Speakers
Lawrence Vernetti
Ph.D.
Director of Early Drug Safety
University of Pittsburgh, Pittsburgh, PA
Yves Pommier
MD, PhD
Chief, Developmental Therapeutics Branch, NIH, Bethesda, MD
Ethan Russo
M.D.
Director of R&D, International Cannabis and Cannabinoids Institute, Czech Republic, EU
Paul Dunman
Ph.D.
Principal Investigator, University of Rochester Medical Center, Rochester, NY
Christine Esau
PhD
Vice President of Drug Discovery at Genevant Sciences
Boston, MA
Brian Schneider
MBA, PhD
Sr. Territory Account Manager, Synthego, Redwood City, CA
Drug Discovery-2019 Speakers
David M. Lovinger, Ph.D.
Chief, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD
Klaus Gawrisch, Ph.D.
Chief, Section of NMR Chief, Laboratory of Membrane Biochemistry and Biophysics, NIAAA, NIH, Bethesda, MD
Elmar Nurmemmedov, Ph.D., MBA
Director of Drug Discovery, Principal Investigator of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Santa Monica, CA
Sven Korte, Ph.D.
Study Director
Covance Preclinical Services GmbH
Münster, Germany
Covance Preclinical Services GmbH
Münster, Germany
Marina Seme-Nelson, Ph.D.
Drug Development Leader
Covance Inc.
Madison, WI
Covance Inc.
Madison, WI
Stephanie C. Oestreich, MPA
EVP, Head BRIDGEs Partnerships North America
Evotec (US) Inc., USA
Evotec (US) Inc., USA
Thomas Webster, Ph.D.
Department Chair, Chemical Engineering
Northeastern University
MA, USA
Northeastern University
MA, USA
Maria Kontoyianni, Ph.D.
Professor
Southern Illinois University Edwardsville
Edwardsville, IL
Southern Illinois University Edwardsville
Edwardsville, IL
Igor Kovalchuk, M.D., Ph.D.
Professor, Department of Biological Sciences, University of Lethbridge
Canada
Canada
Paul C. Trippier, Ph.D.
Department of Pharmaceutical Sciences
University of Nebraska Medical Center, Omaha, NE
University of Nebraska Medical Center, Omaha, NE
Ravindra Peravali, Ph.D.
Head, Screening Center, Institute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology, Germany
Dana M. Lambert, B.Sc.(Pharm), R.Ph., Ph.D.
Founder, Principal Pharmaceutical Inventor and CEO, Andira Pharmaceuticals,
Vancouver, Canada
Alexander McCampbell, Ph.D.
Senior Director
Principal Neurology Scientist
Biogen, Boston, MA
Principal Neurology Scientist
Biogen, Boston, MA
Anna Jacobs, Ph.D.
Scientist
Walter Reed Army Institute of Research
Silver Spring, MD
Walter Reed Army Institute of Research
Silver Spring, MD
Rachel Wozniak, MD, Ph.D
Assistant Professor, Ophthalmology
Flaum Eye Institute
University of Rochester Medical Center, NY
Flaum Eye Institute
University of Rochester Medical Center, NY
Cynthia Dowd, Ph.D.
Associate Professor, Department of Chemistry, George Washington University
Washington, DC
Washington, DC
Weike Mo, Ph.D.
Vice President, Digital China Health
Clinical and Genomic Data Services
China
Clinical and Genomic Data Services
China
Yan Yuan, Ph.D.
Professor, Department of Microbiology
University of Pennsylvania
Philadelphia, PA
University of Pennsylvania
Philadelphia, PA
Annette M. Tobia, PhD., JD
Founder and Chief Scientific Officer
Dynamis Pharmaceuticals, Inc., Jenkintown, PA
Dynamis Pharmaceuticals, Inc., Jenkintown, PA
Michael Graziano, PhD.
Chief Scientific Officer
TARA Biosystems, Inc.
New York, NY
TARA Biosystems, Inc.
New York, NY
Mu Yuguang, PhD.
Assoc. Prof., School of Biological Sciences, Nanyang Technological University, Singapore
Douglas K. Graham, M.D., PhD.
Professor and Director, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA
Alexandros Makriyannis, PhD.
George D Behrakis Chair, Director
Center for Drug Discovery, Northeastern University, Boston, MA
Center for Drug Discovery, Northeastern University, Boston, MA
Søren Warming, PhD.
Associate Director and Senior Scientist
Department Head, Molecular Biology
Genentech, Inc., San Francisco, CA
Department Head, Molecular Biology
Genentech, Inc., San Francisco, CA
Liang Tong, PhD.
William R. Kenan, Jr. Professor
Department of Biological Sciences
Columbia University, New York, NY
Department of Biological Sciences
Columbia University, New York, NY
Ourania M. Andrisani, PhD.
Professor, Basic Medical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, IN
Norbert Pardi, PhD.
Research Assistant Professor of Medicine, University of Pennsylvania
Philadelphia, PA
Philadelphia, PA
David Butler, PhD.
Vice President & Senior Director
Wave Life Sciences
Medford, MA
Wave Life Sciences
Medford, MA
Deborah W. Knapp, DVM, MS
Director, Purdue Comparative Oncology Program, Purdue University College of Veterinary Medicine, West Lafayette, IN
David Evans, Ph.D
Chief Scientific Officer
Sirnaomics, Inc.
Gaithersburg, MD
Sirnaomics, Inc.
Gaithersburg, MD
Catherine Adamson, Ph.D
Biomedical Sciences Research Complex
University of St Andrews
St Andrews, Scotland
University of St Andrews
St Andrews, Scotland
Adam Simon, Ph.D
Scientist - AI & Chemistry
Qulab Inc.
Los Angeles, CA
Qulab Inc.
Los Angeles, CA
Andrea Kasinski, Ph.D
William and Patty Miller Assistant Professor of Biological Sciences, Purdue University, West Lafayette, IN
Cynthia Lichorowic, Ph.D
Research Scientist
Aerie Pharmaceuticals, Inc.
Durham, NC
Aerie Pharmaceuticals, Inc.
Durham, NC
Ryan Bennett, Ph.D
Chief Scientific Officer
OyaGen, Inc.
Rochester, NY
OyaGen, Inc.
Rochester, NY
Robert Ricciardi, Ph.D
Professor & Chair
Department of Microbiology
University of Pennsylvania, PA
Department of Microbiology
University of Pennsylvania, PA
Paolo Lombardi, Ph.D
Naxospharma S.R.L.
Novate Milanese MI, Italy
Novate Milanese MI, Italy
Tinghu Zhang, Ph.D
Lead Scientist
Dana-Farber Cancer Institute
Boston, MA
Dana-Farber Cancer Institute
Boston, MA
Sathees C. Raghavan, Ph.D
Professor
Department of Biochemistry Indian Institute of Science Bangalore, India
Department of Biochemistry Indian Institute of Science Bangalore, India
Taleb H. Al-Tel, Ph.D
Director
Research Institute for Medical & Health Sciences, University of Sharjah, UAE
Research Institute for Medical & Health Sciences, University of Sharjah, UAE
Helen Yu, LLB, JD, Ph.D
Associate Director, Centre for Advanced Studies in Biomedical Innovation Law, University of Copenhagen, Denmark
Raman Bahal, Ph.D
Department of Pharmaceutical Sciences, University of Connecticut, CT
John D. Lueck, Ph.D
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY
